Regeneron’s New Drug Offers Hope for Blood Cancer Patients

Based on a report by Reuters A new treatment from Regeneron Pharmaceuticals has been approved by the U.S. Food and Drug Administration (FDA) for patients with a recurring form of blood cancer known as multiple myeloma. This approval marks a significant development for those who have already undergone four or more previous therapies. The drug, […]